Free Access
Vet. Res.
Volume 39, Number 6, November-December 2008
Number of page(s) 13
Published online 09 September 2008
How to cite this article Vet. Res. (2008) 39:60
References of  Vet. Res. (2008) 39:60
  1. Adams M.M., van Leeuwen B.H., Kerr P.J., Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions, Vaccine (2007) doi:10.1016/j.vaccine.2008.08.036.
  2. Bárcena J., Morales M., Vázquez B., Boga J.A., Parra F., Lucientes J., et al., Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus, J. Virol. (2000) 74:1114–1123 [CrossRef] [PubMed].
  3. Barrett J.W., Shun Chang C., Wang G., Werden S.J., Shao Z., Barrett C., et al., Myxoma virus M063R is a host range gene essential for virus replication in rabbit cells, Virology (2007) 361:123–132 [CrossRef] [PubMed].
  4. Bertagnoli S., Gelfi J., Le Gall G., Boilletot E., Vautherot J.F., Rasschaert D., Laurent S., et al., Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein, J. Virol. (1996) 70:5061–5066 [PubMed].
  5. Best S.M., Collins S.V., Kerr P.J., Coevolution of host and virus: cellular localization of myxoma virus infection of resistant and susceptible European rabbits, Virology (2000) 277:76–91 [CrossRef] [PubMed].
  6. Best S.M., Kerr P.J., Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits, Virology (2000) 267: 36–48.
  7. Brun A., Godard A., Moreau Y., La vaccination contre la myxomatose: vaccins hétérologues et homologues, Bull. Soc. Vet. Med. Comp. (1981) 83:251–254.
  8. Cao J.X., Upton C., gpt-gus fusion gene for selection and marker in recombinant poxviruses, Biotechniques (1997) 22:276–278 [PubMed].
  9. Fenner F., Woodroofe G.M., Protection of laboratory rabbits against myxomatosis by vaccination with fibroma virus, Aust. J. Exp. Biol. Med. Sci. (1954) 32:653–668 [CrossRef] [PubMed].
  10. Fenner F., Ratcliffe F.N., Myxomatosis, Cambridge University Press, Cambridge, UK, 1965.
  11. Fenner F., Fantini B., Biological control of vertebrate pests. The history of myxomatosis — an experiment in evolution, CAB International, Wallingford, UK, 1999.
  12. Fountain S., Holland M.K., Hinds L.A., Janssens P.A., Kerr P.J., Interstitial orchitis with impaired steroidogenesis and spermatogenesis in the testes of rabbits infected with an attenuated strain of myxoma virus, J. Reprod. Fertil. (1997) 110:161–169 [PubMed].
  13. Górski J., Mizak B., Chroboci'nska M., Control of rabbit myxomatosis in Poland, Rev. Off. Int. Epizoot. (1994) 13:869–879.
  14. Jerabek J., Applicability of Shope fibroma virus replicated in cell cultures for immunoprophylaxis of rabbit myxomatosis, Acta Vet. Brno (1980) 49:259–267.
  15. Kerr P.J., An ELISA for epidemiological studies of myxomatosis: persistence of antibodies to myxoma virus in European rabbits (Oryctolagus cuniculus), Wildl. Res. (1997) 24:53–65 [CrossRef].
  16. Kerr P.J., Perkins H.D., Inglis B., Stagg R., McLaughlin E., Collins S.V., van Leeuwen B.H., Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis, Virology (2004) 324:117–128 [CrossRef] [PubMed].
  17. Mackenzie S.M., McLaughlin E.A., Perkins H.D., French N., Sutherland T., Jackson R.J., et al., Immunocontraceptive effects on female rabbits infected with recombinant myxoma virus expressing rabbit ZP2 and ZP3, Biol. Reprod. (2006) 74:511–521 [CrossRef] [PubMed].
  18. Marlier D., Mainil J., Boucraut-Baralon C., Linden A., Vindevogel H., The efficacy of two vaccination schemes against experimental infection with a virulent amyxomatous or a virulent nodular myxoma virus strain, J. Comp. Pathol. (2000) 122: 115–122.
  19. McCurdy L.H., Larkin B.D., Martin J.E., Graham B.S., Modified vaccinia Ankarra: potential as a smallpox vaccine, Clin. Infect. Dis. (2004) 38:1749–1753 [CrossRef] [PubMed].
  20. Mckercher D.G., Saito J.K., An attenuated live virus vaccine for myxomatosis, Nature (1964) 202:933–934 [CrossRef] [PubMed].
  21. Meng X., Chao J., Xiang Y., Identification from diverse mammalian poxviruses of hostrange regulatory genes functioning equivalently to vaccinia virus C7L, Virology (2008) 372:372–383 [CrossRef] [PubMed].
  22. Mykytowycz R., An attenuated strain of the myxomatosis virus recovered from the field, Nature (1953) 172:448–449 [CrossRef] [PubMed].
  23. Picavet D.P., Lebas F., Gilbert E., Brignol E., Immunisation of rabbits against myxomatosis with an homologous vaccine, Rev. Med. Vet. (1989) 140:823–827 (in French).
  24. Ramsey-Ewing A.L., Moss B., Complementation of a vaccinia virus host-range K1L gene deletion by the non-homologous CP77 gene, Virology (1996) 222: 75–86.
  25. Robinson A.J., Müller W.J., Braid A.L., Kerr P.J., The effect of buphrenorphine on the course of disease in laboratory rabbits infected with myxoma virus, Lab. Anim. (1999) 33:252–257 [CrossRef] [PubMed].
  26. Russell R.J., Robbins S.J., Cloning and molecular characterization of the myxoma virus genome, Virology (1989) 170:147–159 [CrossRef] [PubMed].
  27. Saurat P., Gilbert Y., Ganiere J.-P., Study on myxomatous virus modified strain, Rev. Med. Vet. (1978) 129:415–451 (in French).
  28. Stanford M.M., Werden S.J., McFadden G., Myxoma virus in the European rabbit: interactions between the virus and its susceptible host, Vet. Res. (2007) 38:299–318 [CrossRef] [PubMed] [EDP Sciences].
  29. Torres J.M., Ramírez M.A., Morales M., Bárcena J., Vázquez B., Espuña E., et al., Safety evaluation of a recombinant myxoma-RHDV virus inducing horizontal transmissible protection against myxomatosis and rabbit haemorrhagic disease, Vaccine (2000) 19:174–182 [CrossRef] [PubMed].
  30. Torres J.M., Sánchez C., Ramírez M.A., Morales M., Bárcena J., Ferrer J., et al., First field trial of a transmissible recombinant vaccine against myxomatosis and rabbit hemorrhagic disease, Vaccine (2001) 19:4536–4543 [CrossRef] [PubMed].